PTSD

Graphic image of someone overwhelmed and with brain discomfort or headaches
Biotech

Transcend links MDMA analog to PTSD improvements in phase 2

Transcend linked its MDMA analog to improvements in PTSD symptoms that began on Day 8 and persisted through Day 64 of its phase 2 trial.
Nick Paul Taylor Mar 31, 2025 8:00am
boxing punch blow hit punching bag fight

Lykos 'regrets' not disclosing study violations with publisher

Aug 12, 2024 3:39pm
Image of a neon sign with the word no lit up next to an unlit yes

Lykos' MDMA treatment for PTSD has been quashed at the FDA

Aug 10, 2024 9:07am
treasure map compass

Compass tracks PTSD improvements in midphase psilocybin trial

May 8, 2024 8:07am
Food and Drug Administration

FDA advisers to weigh first psychedelic therapy in early June

May 7, 2024 11:10am
Alzheimers research brain scientist magnifying glass questions neuro

Neuropsych biotech Engrail closes $157M series B

Mar 19, 2024 8:00am